Sorry, you need to enable JavaScript to visit this website.


PEAPACK, N.J., January 2013 — Greenstone LLC, a U.S.-based generic pharmaceutical subsidiary of Pfizer Inc. (NYSE: PFE), is pleased to announce the introduction of Atorvastatin Calcium Tablets to its ever-expanding generic pharmaceutical product line. The product is offered in dosage strength of 10mg x 90; 10mg x 1,000; 20mg x 90; 20mg x 1,000; 40mg x 90; 40mg x 500; 80mg x 90; 80mg x 500.

Greenstone’s Atorvastatin Calcium Tablets product is the authorized generic of, and equivalent to the innovator’s product, LIPITOR® (atorvastatin calcium tablets). Their new authorized generic adds to Greenstone’s consistently growing line of products, and is backed by the power and scale of Pfizer’s 163-year worldwide reputation for a commitment to integrity, quality, and supply reliability. As a subsidiary of Pfizer, Greenstone operates under the same values and commitment to bring quality authorized generics to customers, payers, and the patients they serve.

See the Full Prescribing Information, for Greenstone’s Atorvastatin Calcium Tablets at For more information about Greenstone LLC and its products, visit .